Source: FORT MILL TIMES

Cadence Pharmaceuticals: SHAREHOLDER DEADLINE: Law Office of Brodsky & Smith, LLC Announces Investigation of Cadence Pharmaceuticals, Inc. in Connection With the Sale of the Company to Mallinckrodt plc

Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Cadence Pharmaceuticals, Inc. (“Cadence” or the “Company”) (Nasdaq: CADX) relating…Click to Continue »

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Theodore Schroeder's photo - President & CEO of Cadence Pharmaceuticals

President & CEO

Theodore Schroeder

CEO Approval Rating

91/100

Read more